Related Experiment Video
Updated: May 8, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
[Use of the PMSI for the detection of adverse drug reactions]
Marie-Noëlle Osmont1, Marc Cuggia, Elisabeth Polard
1Centre régional de Pharmacovigilance, CHU Pontchaillou, Rennes, France.
Aim:
To evaluate the performance of a query on international classification of diseases 10(th) version (ICD10) codes in the database of the programme for the medicalisation of information systems (programme de médicalisation des systèmes d'information, PMSI) to identify serious adverse drug reactions (ADR).
Methods:
The query concerned hospital stays of patients discharged from the French University Hospital of Rennes in 2009. All the hospitalization summaries including a selected ICD10 code were analysed to validate ADR.
Results:
Out of 383 cases, 142 cases were validated (37.1%). Performance of some ICD10 codes was particularly interesting, above 40% (T88.6, L27.0, J70.4, G62.0 and N14.1) and 79.5% of the ADR were detected by these five codes. During the study period, 98 ADR of the same type were spontaneously reported by physicians, 22 of which were common with the ICD10 query.
Conclusions:
The use of PMSI can be a tool for signal detection of serious ADR, in addition to spontaneous reporting.
Insights
International Classification of Diseases 10th version (ICD10) codes in French hospital discharge data can identify serious adverse drug reactions (ADR). This method complements spontaneous reporting for enhanced patient safety.
Area of Science:
- Pharmacovigilance
- Health Informatics
- Drug Safety
Background:
- Serious adverse drug reactions (ADR) pose a significant public health challenge.
- Effective methods for detecting ADR are crucial for patient safety and regulatory oversight.
- Current pharmacovigilance relies heavily on spontaneous reporting, which has limitations.
Purpose of the Study:
- To assess the utility of International Classification of Diseases 10th version (ICD10) codes within the French hospital discharge database (Programme de médicalisation des systèmes d'information, PMSI) for identifying serious ADR.
- To evaluate the performance of specific ICD10 codes in detecting ADR.
Main Methods:
- A query was designed using specific ICD10 codes.
- The query targeted hospital discharge records from the French University Hospital of Rennes for the year 2009.
- Hospitalization summaries containing selected ICD10 codes were analyzed to validate potential ADR.
Main Results:
- Out of 383 identified cases, 142 (37.1%) were validated as serious ADR.
- Five specific ICD10 codes (T88.6, L27.0, J70.4, G62.0, N14.1) demonstrated performance above 40% and collectively detected 79.5% of the ADR.
- The ICD10 query identified 22 ADR that were also spontaneously reported during the study period.
Conclusions:
- The Programme de médicalisation des systèmes d'information (PMSI) database, utilizing ICD10 codes, shows promise as a tool for detecting serious ADR signals.
- This data-driven approach can serve as a valuable supplement to traditional spontaneous reporting systems for pharmacovigilance.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Risk factors
Drug toxicity: Drug–Drug Interaction
